Edition:
United Kingdom

Jubilant Life Sciences Ltd (JULS.NS)

JULS.NS on National Stock Exchange of India

748.45INR
8:50am GMT
Change (% chg)

Rs-43.30 (-5.47%)
Prev Close
Rs791.75
Open
Rs760.00
Day's High
Rs761.80
Day's Low
Rs740.55
Volume
378,899
Avg. Vol
361,571
52-wk High
Rs1,039.00
52-wk Low
Rs586.35

Latest Key Developments (Source: Significant Developments)

India's Jubilant Life Sciences Sept-Quarter Profit Rises
Monday, 22 Oct 2018 

Oct 22 (Reuters) - Jubilant Life Sciences Ltd ::SEPT QUARTER CONSOL NET PROFIT 2.10 BILLION RUPEES VERSUS PROFIT OF 1.28 BILLION RUPEES LAST YEAR.CONSENSUS FORECAST FOR SEPT QUARTER CONSOL NET PROFIT WAS 2.16 BILLION RUPEES.SEPT QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 22.69 BILLION RUPEES VERSUS 16.42 BILLION RUPEES LAST YEAR.JUBILANT LIFE SCIENCES LTD - EXPECTS BETTER PERFORMANCE IN H2FY19 AS COMPARED TO H1FY19 IN BOTH PHARMACEUTICALS AND LSI SEGMENTS.  Full Article

Jubilant Life Sciences May Offer Up To 5% Of Share Capital Of JPL To Raise Funds
Friday, 27 Jul 2018 

July 27 (Reuters) - Jubilant Life Sciences Ltd ::JUBILANT LIFE SCIENCES - BOARD APPROVED THAT IF THERE'S OPPORTUNITY IN FUND RAISING BY UNIT, CO MAY OFFER UP TO 5% OF SHARE CAPITAL OF JPL FOR SALE.  Full Article

Jubilant Life Sciences, Jubilant Stock Holding, Others File Appeals Against SEBI Adjudication Order
Wednesday, 25 Apr 2018 

April 25 (Reuters) - Jubilant Life Sciences Ltd ::CO, JUBILANT STOCK HOLDING, OTHERS FILED APPEALS BEFORE SECURITIES APPELLATE TRIBUNAL AGAINST SEBI ADJUDICATION ORDER.  Full Article

India's Jubilant Life Sciences Dec Qtr Consol Profit Up 78 Pct
Wednesday, 17 Jan 2018 

Jan 17 (Reuters) - Jubilant Life Sciences Ltd ::DEC QUARTER CONSOL NET PROFIT 2.13 BILLION RUPEES VERSUS PROFIT OF 1.19 BILLION RUPEES LAST YEAR.DEC QUARTER TOTAL REVENUE FROM OPERATIONS 20.68 BILLION RUPEES VERSUS 14.92 BILLION RUPEES LAST YEAR.  Full Article

Jubilant Life Sciences Unit Gets sNDA Approval For New Indications From USFDA For Draximage DTPA
Thursday, 28 Dec 2017 

Dec 28 (Reuters) - Jubilant Life Sciences Ltd ::SAYS UNIT GETS SNDA APPROVAL FOR NEW INDICATIONS FROM USFDA FOR DRAXIMAGE® DTPA.  Full Article

Jubilant Life Sciences Says Co Not Got Formal Environmental Nod For Gujarat Pesticide Project
Monday, 4 Dec 2017 

Dec 4 (Reuters) - Jubilant Life Sciences Ltd ::CLARIFIES ON NEWS ITEM ON CO'S PESTICIDE PROJECT IN GUJARAT GETTING GREEN PANEL NOD.SAYS CO HAS NOT GOT ANY FORMAL ENVIRONMENTAL NOD FOR GUJARAT PESTICIDE PROJECT.  Full Article

Jubilant Life Sciences says received ANDA approval for Indomethacin capsules USP
Monday, 28 Aug 2017 

Aug 28 (Reuters) - Jubilant Life Sciences Ltd ::Says Jubilant receives ANDA approval for Indomethacin capsules USP.Says drug is a nonsteroidal anti-inflammatory drug used for treatment of moderate to severe inflammation and reduce pain.  Full Article